|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$327,420
|
$32,742
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$279,762
|
$97,917
|
Aplan, Peter
|
CCR (NCI)
|
|
Antibody-based therapeutics and vaccines against AIDS
|
ZIA BC 011155
|
$287,030
|
$143,515
|
Dimitrov, Dimiter
|
CCR (NCI)
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
$10,424
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-08
|
$749,588
|
$14,992
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Biochemical Basis of T Cell Activation
|
ZIA BC 010304
|
$1,107,977
|
$553,988
|
Samelson, Lawrence
|
CCR (NCI)
|
|
Bone Marrow Grafting for Leukemia and Lymphoma
|
5P01CA049605-21
|
$3,525,298
|
$387,783
|
NEGRIN, ROBERT
|
STANFORD UNIVERSITY
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-34
|
$3,012,562
|
$753,141
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Branch Clinical Research Core
|
ZID BC 010963
|
$1,239,800
|
$123,980
|
Gress, Ronald
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,313,626
|
$65,681
|
Restifo, Nicholas
|
CCR (NCI)
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$1,434
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$116,889
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer risk in x-ray technologists
|
ZIA CP010133-04180
|
$1,340,943
|
$26,819
|
Linet
|
DCEG (NCI)
|
|
Cancer Vaccines and Modulation of Checkpoint Controls in Immunization
|
ZIC BC 010630
|
$616,122
|
$61,612
|
Janik, John
|
CCR (NCI)
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-15
|
$1,893,674
|
$189,367
|
Robison, Leslie
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-07S3
|
$749,797
|
$104,972
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-07
|
$27,646,062
|
$3,870,449
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-07
|
$5,725,544
|
$801,576
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Chimeric T Cell for Therpay of Hodgkin Disease
|
5R01CA131027-02
|
$318,513
|
$318,513
|
SAVOLDO, BARBARA
|
BAYLOR COLLEGE OF MEDICINE
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-05S1
|
$1,079,832
|
$539,916
|
forman, stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Clinical Activity of MGCD-0103 in Hodgkin Lymphoma
|
5R21CA133876-02
|
$250,200
|
$250,200
|
YOUNES, ANAS
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
CLL Families-Mayo
|
ZIA CP004410-10312
|
$213,286
|
$10,664
|
Caporaso
|
DCEG (NCI)
|
|
Clonal expansion of lymphocytes in multiple cohorts
|
ZIA CP010176-10092
|
$113,856
|
$5,693
|
Rabkin
|
DCEG (NCI)
|
|
Community Clinical Oncology program Research Base
|
5U10CA095861-08
|
$2,126,089
|
$297,652
|
POLLOCK, BRAD
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-26
|
$382,772
|
$30,622
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
Consolidated Basic Cancer Research Program
|
2P30CA010815-40
|
$2,527,733
|
$75,832
|
KAUFMAN, RUSSEL
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-40S2
|
$98,063
|
$2,942
|
KAUFMAN, RUSSEL
|
WISTAR INSTITUTE
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-23
|
$1,282,700
|
$12,827
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT
|
ZIA BC 010698
|
$167,837
|
$25,176
|
Bishop, Michael
|
CCR (NCI)
|
|
Development of Novel Therapies for HIV Infection
|
ZIA SC 006737
|
$422,772
|
$84,554
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Discovery of inhibitors of ALK for the treatment of cancer
|
1R43CA139842-01A1
|
$328,829
|
$108,514
|
MEADOWS, Vicki
|
ZENOBIA THERAPEUTICS, INC
|
|
Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD
|
5R01CA133063-02
|
$274,204
|
$137,102
|
Longnecker, Richard
|
NORTHWESTERN UNIVERSITY
|
|
DNA Repair
|
ZIA BC 010283
|
$784,092
|
$133,296
|
Nussenzweig, Andre
|
CCR (NCI)
|
|
Dose-Response in Radionuclide Therapy
|
5R01CA116477-04
|
$397,575
|
$131,200
|
SGOUROS, GEORGE
|
JOHNS HOPKINS UNIVERSITY
|
|
Duluth Community Clinical Oncology Program
|
5U10CA035269-26
|
$747,046
|
$14,941
|
Nikcevich, Daniel
|
DULUTH CLINIC, LTD.
|
|
EBV Genome Expression:Localization of Specific Functions
|
5R01CA030356-28
|
$330,440
|
$33,044
|
HAYWARD, S
|
JOHNS HOPKINS UNIVERSITY
|
|
EBV's Plasmid Replicon: Its Synthesis, Partitioning, and Maintenance of Tumors
|
5R01CA133027-02
|
$300,378
|
$150,189
|
SUGDEN, WILLIAM
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Enhanced Self-Appraisal After Cancer: A Bias in Survivors' Self-Report?
|
1R03CA134159-01A2
|
$84,552
|
$84,552
|
Recklitis, Christopher
|
DANA-FARBER CANCER INSTITUTE
|
|
EORTC DATA CENTER
|
5U10CA011488-39
|
$809,323
|
$24,280
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Epstein-Barr Virus LMP-1 Mediated Oncogenicity
|
5R01CA085180-09
|
$725,501
|
$725,501
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation
|
5R01CA047006-22
|
$560,086
|
$280,043
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Experimental Therapeutics of Pediatric Hematopoietic Malignancies
|
ZIC SC 010353
|
$854,426
|
$42,721
|
Wayne, Alan
|
CCR (NCI)
|
|
Family Studies
|
ZIA CP004410-08167
|
$160,190
|
$152,181
|
A Tucker, Margaret
|
DCEG (NCI)
|
|
FASEB Conference-Hematological Malignancies
|
5R13CA117424-03
|
$9,710
|
$1,942
|
ZHANG, DONG-ER
|
FEDERATION OF AMER SOC FOR EXPER BIOLOGY
|
|
Function of granulysin
|
ZIA BC 011026
|
$666,916
|
$100,037
|
Krensky, Alan
|
CCR (NCI)
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-26
|
$610,000
|
$12,200
|
Bernath, Albert
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
|
Genetic Epidemiology
|
ZIA CP005803-00355
|
$227,194
|
$56,798
|
M Goldstein, Alisa
|
DCEG (NCI)
|
|
GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM
|
5U10CA035178-26
|
$1,278,666
|
$25,573
|
Bury, Martin
|
SPECTRUM HEALTH HOSPITALS
|
Total relevant funding to Hodgkins disease for this search: $18,224,261
|